Survival following liver transplantation: A population-based nested case-control study - 22/02/24
, Alejandro Suarez-Pierre a, Jason J. Breithaupt a, Dor Yoeli a, Ioannis A. Ziogas a, Rashikh A. Choudhury a, b, Trevor L. Nydam a, b, James J. Pomposelli a, b, Elizabeth A. Pomfret a, b, Megan A. Adams a, b, cAbstract |
Background |
Liver transplantation is the gold standard treatment for end-stage liver disease. This study evaluates post-transplantation survival compared with the general population by quantifying standardized mortality ratios in a nested case-control study.
Methods |
Controls were noninstitutionalized United States inhabitants from the National Longitudinal Mortality Study. Cases underwent liver transplantation from 1990 to 2007 identified through the Organ Procurement and Transplantation Network database. Propensity matching (5:1, nearest neighbor, caliper 0.1) identified controls based on age, sex, race, and state. The primary endpoint was 10-year survival.
Results |
62,788 cases were matched to 313,381 controls. The overall standardized mortality ratio was 2.46 (95% CI = 2.44–2.48). The standardized mortality ratio was higher for males (2.59 vs. 2.25) and Hispanic patients (4.80). Younger patients and those transplanted earlier (1990–1995) had higher standardized mortality ratios.
Conclusions |
Liver recipients have a standardized mortality ratio 2.46 times higher than the general population. Long-term mortality has declined over time.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Standardized mortality was higher for males, Hispanic patients, and earlier eras. |
• | Standardized mortality decreased proportionally with increasing age. |
• | Liver transplant recipients had lower incidence of death from cardiovascular causes. |
Keywords : Liver transplantation, Mortality, Postoperative complications, Organ transplantation, Actuarial analysis, Cause of death
Plan
Vol 228
P. 264-272 - février 2024 Retour au numéro
Article précédent
- Is therapeutic lymph node dissection of value for lymph node recurrence in melanoma?
- Ana K. Wilson, Kristel Lourdault, Tara Ostad, Stacey Stern, Richard Essner
- The efficacy of neoadjuvant chemotherapy is different for type 4 and large type 3 gastric cancer
- Wei Xu, Lingquan Wang, Wentao Liu, Chen Li, Xuexin Yao, Mingmin Chen, Min Yan, Zhenggang Zhu, Chao Yan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?